Agency
The FDA regulates food, drugs, biologics, medical devices, and tobacco. We aggregate Class I, II, and III enforcement actions across its three recall streams.
Pending LLM rewrite. Source: FDA_DEVICE Z-1798-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1800-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1819-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1810-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1803-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1817-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1818-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1802-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1799-2026.
Connecticut Crab Company LLC is recalling crab cakes sold to food service in New York and New Jersey due to potential temperature abuse that may allow growth of Clostridium botulinum.
Pure Vitamins and Natural Supplements, LLC is recalling Boner Bears Honey Male Enhancement because FDA testing found undeclared sildenafil and tadalafil, prescription drugs not listed on the label.
Zarlengo Italian Ice is recalling Zarlengo's Double Dark Chocolate Gelato in 1-gallon buckets because soy lecithin is listed in the ingredients but soy is not disclosed in the allergen statement, posing a risk to consumers with soy allergies.
Zarlengo Italian Ice is recalling Chocolate Chocolate Chip Gelato in multiple sizes because soy lecithin is listed in the ingredients but soy is not declared in the allergen statement, posing a risk to consumers with soy allergies.
Blueroot Health, Inc. is recalling Vital Nutrients Aller-C vitamin supplements because they contain undeclared egg, soy, and hazelnut allergens, posing a risk to consumers with allergies to these ingredients.
Pending LLM rewrite. Source: FDA_FOOD H-0654-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0657-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0655-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0658-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0668-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0651-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0427-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0424-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0445-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0441-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0473-2026.